Avidity Biosciences
RNAM
#1793
Rank
ยฃ8.49 B
Marketcap
ยฃ55.02
Share price
0.00%
Change (1 day)
141.88%
Change (1 year)

Revenue for Avidity Biosciences (RNAM)

Revenue in 2025 (TTM): ยฃ13.93 Million

According to Avidity Biosciences's latest financial reports the company's current revenue (TTM ) is ยฃ14.16 Million. an increase over the revenue in the year 2024 that were of ยฃ8.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avidity Biosciences from 2019 to 2025

Annual revenue

Year Revenue Change
2025 ยฃ13.92 M60.38%
2024 ยฃ8.68 M15.72%
2023 ยฃ7.5 M-1.58%
2022 ยฃ7.62 M10.35%
2021 ยฃ6.9 M38.76%
2020 ยฃ4.97 M181.56%
2019 ยฃ1.76 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
ยฃ47.27 B 333,565.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ33.07 B 233,292.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
ยฃ1.82 B 12,769.71%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
ยฃ1.30 B 9,127.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
ยฃ5.39 M-61.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
ยฃ87.38 M 516.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
ยฃ85.19 M 501.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ0.44 B 3,040.44%๐Ÿ‡บ๐Ÿ‡ธ USA